Merck to invest $1B in new US plant to make blockbuster cancer treatment Keytruda
1. Merck invests $1 billion in a Delaware plant for domestic production. 2. The facility will produce biologic drugs and Keytruda cancer treatment. 3. Merck faces $200 million in additional costs due to tariffs on Keytruda. 4. The plant aims to create 500 permanent jobs and 4,000 construction jobs. 5. The facility will be operational by 2028, producing drugs by 2030.